{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:25:52Z","timestamp":1791170752684,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd007514.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,7,8]],"date-time":"2014-07-08T00:00:00Z","timestamp":1404777600000}}],"reference-count":105,"publisher":"Wiley","issue":"7","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007514.pub3","type":"journal-article","created":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T15:01:39Z","timestamp":1416495699000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Statins for the treatment of dementia"],"prefix":"10.1002","volume":"2014","author":[{"given":"Bernadette","family":"McGuinness","sequence":"first","affiliation":[{"name":"Belfast Health and Social Care Trust; Department of Geriatric Medicine; Lisburn Road Belfast Co Antrim UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Craig","sequence":"additional","affiliation":[{"name":"Craigavon Area Hospital; Geriatric Medicine; Craigavon Northern Ireland UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Bullock","sequence":"additional","affiliation":[{"name":"Kingshill Research Centre, Victoria Hospital; Okus Road Swindon UK SN4 4HZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem","family":"Malouf","sequence":"additional","affiliation":[{"name":"University of Oxford; National Perinatal Epidemiology Unit (NPEU); Old Road Campus Oxford UK OX3 7LF"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Passmore","sequence":"additional","affiliation":[{"name":"Queen's University Belfast; Centre for Public Health; Block B, ICSB, Grosvenor Road Belfast Northern Ireland UK BT12"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,7,8]]},"reference":[{"issue":"Suppl 185","key":"10.1002\/14651858.CD007514.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1600-0404.2006.00690.x","article-title":"Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trial","volume":"114","author":"Sparks","year":"2006","journal-title":"Acta Neurologica Scandinavica"},{"issue":"Suppl 185","key":"10.1002\/14651858.CD007514.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1600-0404.2006.00689.x","article-title":"Statin therapy in Alzheimer's disease","volume":"114","author":"Sparks","year":"2006","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1002\/14651858.CD007514.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archneur.62.5.753","article-title":"Atorvastatin for the treatment of mild to moderate Alzheimer disease","volume":"62","author":"Sparks","year":"2005","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD007514.pub3-BIB0004|cit4","first-page":"153","article-title":"The LEADe study: a randomized, controlled trial investigating the effect of atorvastatin on cognitive and global function in patients with mild-to-moderate Alzheimer's disease receiving background therapy of donepezil","volume":"71","author":"Feldman","year":"2008","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD007514.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1212\/WNL.0b013e3181d6476a","article-title":"Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease. LEADe","volume":"74","author":"Feldman","year":"2010","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD007514.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jalz.2008.02.001","article-title":"The Atorvastatin\/Donepezil in Alzheimer's Disease Study (LEADe): design and baseline characteristics","volume":"4","author":"Jones","year":"2008","journal-title":"Alzheimer's & Dementia"},{"key":"10.1002\/14651858.CD007514.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1212\/WNL.0b013e318228bf11","article-title":"A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease","volume":"77","author":"Sano","year":"2011","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD007514.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/ana.10292","article-title":"Treatment with simvastatin in normocholesterolaemic patients with Alzheimer's disease: a 26-week randomized, placebo-controlled, double-blind trial","volume":"52","author":"Simons","year":"2002","journal-title":"Annals of Neurology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD007514.pub3-BIB0009|cit9","first-page":"S92","article-title":"Cognitive maintenance of Alzheimer's disease patients in pooled randomized, placebo-controlled clinical trials of galantamine: the effect of statins","volume":"5","author":"Gutterman","year":"2002","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD007514.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2165\/00002512-200724010-00004","article-title":"Effects of statins on cognitive function in patients with Alzheimer's disease in galantamine clinical trials","volume":"24","author":"Winbald","year":"2007","journal-title":"Drugs Aging"},{"key":"10.1002\/14651858.CD007514.pub3-BIB0011|cit11","unstructured":"Alzheimers Disease International Dementia statistics www.alz.co.uk\/research\/statistics"},{"issue":"2","key":"10.1002\/14651858.CD007514.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000017215","article-title":"Neuropathological substrates of dementia and depression in vascular dementia, with a particular focus on cases with small infarct volumes","volume":"11","author":"Ballard","year":"2000","journal-title":"Dementia, Geriatric and Cognitive Disorders"},{"issue":"3","key":"10.1002\/14651858.CD007514.pub3-BIB0013|cit13","first-page":"427","article-title":"Brain and optic system pathology in hypocholesterolemic dogs treated with a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase","volume":"132","author":"Berry","year":"1988","journal-title":"American Journal of Pathology"},{"key":"10.1002\/14651858.CD007514.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jstrokecerebrovasdis.2010.11.002","article-title":"Statins, risk of dementia, and cognitive function: secondary analysis of the ginkgo evaluation of memory study","volume":"6","author":"Betterman","year":"2012","journal-title":"Journal of Stroke and Cerebrovascular Disease"},{"issue":"8","key":"10.1002\/14651858.CD007514.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"4436","DOI":"10.1074\/jbc.271.8.4436","article-title":"Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein","volume":"271","author":"Bodovitz","year":"1996","journal-title":"Journal of Biological Chemistry"},{"issue":"7","key":"10.1002\/14651858.CD007514.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1212\/WNL.44.7.1246","article-title":"Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study","volume":"44","author":"Breteler","year":"1994","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD007514.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0169-328X(02)00647-2","article-title":"Co-localization of cholesterol, apolipoprotein E and fibrillar Abeta in amyloid plaques","volume":"110","author":"Burns","year":"2003","journal-title":"Brain Research. Molecular Brain Research"},{"key":"10.1002\/14651858.CD007514.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1750-1326-2-22","article-title":"The Alzheimer's disease beta-secretase enzyme, BACE1","volume":"2","author":"Cole","year":"2007","journal-title":"Molecular Neurodegeneration"},{"issue":"5123","key":"10.1002\/14651858.CD007514.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1002\/14651858.CD007514.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomized trials of statins","volume":"366","author":"Cholesterol Treatment Trialists' Collaborators (CTTC)","year":"2005","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD007514.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1749-6632.2002.tb04802.x","article-title":"Paraoxonase 1 activity: a new vascular marker of dementia?","volume":"977","author":"Dantoine","year":"2002","journal-title":"Annals of the New York Academic Science"},{"issue":"1-2","key":"10.1002\/14651858.CD007514.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jns.2004.09.005","article-title":"Vascular factors in dementia: an overview","volume":"226","author":"Decarli","year":"2004","journal-title":"Journal of Neurological Science"},{"issue":"2","key":"10.1002\/14651858.CD007514.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00041433-200104000-00003","article-title":"Cholesterol metabolism in the brain","volume":"12","author":"Dietschy","year":"2001","journal-title":"Current Opinions in Lipidology"},{"issue":"1","key":"10.1002\/14651858.CD007514.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1083\/jcb.200207113","article-title":"Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts","volume":"160","author":"Ehehalt","year":"2003","journal-title":"Journal of Cell Biology"},{"issue":"6","key":"10.1002\/14651858.CD007514.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/jnnp.63.6.749","article-title":"Neuropathological assessment of the lesions of significance in vascular dementia","volume":"63","author":"Esiri","year":"1997","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"18","key":"10.1002\/14651858.CD007514.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1001\/jama.1989.03430180093036","article-title":"Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported","volume":"262","author":"Evans","year":"1989","journal-title":"JAMA"},{"issue":"16","key":"10.1002\/14651858.CD007514.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium","volume":"278","author":"Farrer","year":"1997","journal-title":"JAMA"},{"issue":"10","key":"10.1002\/14651858.CD007514.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"5856","DOI":"10.1073\/pnas.081620098","article-title":"Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo","volume":"98","author":"Fassbender","year":"2001","journal-title":"Proceedings of the National Academy of Science USA"},{"key":"10.1002\/14651858.CD007514.pub3-BIB0029|cit29","first-page":"2002","article-title":"The role of statins in Alzheimer's disease: a meta-analysis","volume":"2","author":"Gizachew","year":"2012","journal-title":"African Journal of Neurological Sciences"},{"issue":"5580","key":"10.1002\/14651858.CD007514.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"issue":"10","key":"10.1002\/14651858.CD007514.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ng.440","article-title":"Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease","volume":"41","author":"Harold","year":"2009","journal-title":"Nature Genetics"},{"issue":"5","key":"10.1002\/14651858.CD007514.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1194\/jlr.M500024-JLR200","article-title":"Crossing the barrier: net flux of 27-hydroxycholesterol into the human brain","volume":"46","author":"Heverin","year":"2005","journal-title":"Journal of Lipid Research"},{"issue":"6","key":"10.1002\/14651858.CD007514.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/1531-8249(200006)47:6<739::AID-ANA6>3.0.CO;2-8","article-title":"Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model","volume":"47","author":"Holtzman","year":"2000","journal-title":"Annals of Neurology"},{"issue":"6","key":"10.1002\/14651858.CD007514.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1212\/WNL.45.6.1092","article-title":"Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: a case-control study","volume":"45","author":"Jarvik","year":"1995","journal-title":"Neurology"},{"issue":"5","key":"10.1002\/14651858.CD007514.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/BF00294806","article-title":"Ischemic stress induces deposition of amyloid beta immunoreactivity in human brain","volume":"90","author":"Jendroska","year":"1995","journal-title":"Acta Neuropathology"},{"key":"10.1002\/14651858.CD007514.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(00)03155-X","article-title":"Statins and the risk of dementia","volume":"356","author":"Jick","year":"2000","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD007514.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1211\/146080899128734820","article-title":"Differentiation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors by their relative lipophilicity","volume":"5","author":"Joshi","year":"1999","journal-title":"Pharmacy and Pharmacology Communications"},{"issue":"1-2","key":"10.1002\/14651858.CD007514.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jns.2009.02.352","article-title":"Therapeutic potential of statins in Alzheimer's disease","volume":"283","author":"Kandiah","year":"2009","journal-title":"Journal of the Neurological Sciences"},{"issue":"12","key":"10.1002\/14651858.CD007514.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1592\/phco.23.15.1663.31953","article-title":"Cognitive impairment associated with atorvastatin and simvastatin","volume":"23","author":"King","year":"2003","journal-title":"Pharmacotherapy"},{"issue":"3","key":"10.1002\/14651858.CD007514.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"149","DOI":"10.7326\/0003-4819-137-3-200208060-00006","article-title":"Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease","volume":"137","author":"Kivipelto","year":"2002","journal-title":"Annals of Internal Medicine"},{"issue":"4-5","key":"10.1002\/14651858.CD007514.pub3-BIB0041|cit41","first-page":"269","article-title":"Vascular dementia and systemic changes","volume":"59","author":"Klich-Raczka","year":"2002","journal-title":"Przeglad Lekarski"},{"issue":"7","key":"10.1002\/14651858.CD007514.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1056\/NEJM199908123410707","article-title":"Drug treatment of lipid disorders","volume":"341","author":"Knopp","year":"1999","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD007514.pub3-BIB0043|cit43","first-page":"589","article-title":"Low levels of serum apolipoprotein A I and A II in senile dementia","volume":"48","author":"Kuriyama","year":"1994","journal-title":"Japanese Journal of Psychiatry and Neurology"},{"issue":"10","key":"10.1002\/14651858.CD007514.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ng.439","article-title":"Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease","volume":"41","author":"Lambert","year":"2009","journal-title":"Nature Genetics"},{"issue":"5","key":"10.1002\/14651858.CD007514.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1194\/jlr.M400486-JLR200","article-title":"Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease","volume":"46","author":"Lane","year":"2005","journal-title":"Journal of Lipid Research"},{"key":"10.1002\/14651858.CD007514.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/ana.21053","article-title":"Simvastatin enhances learning and memory independent of amyloid load in mice","volume":"60","author":"Li","year":"2006","journal-title":"Annals of Neurology"},{"issue":"9","key":"10.1002\/14651858.CD007514.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1212\/01.wnl.0000277657.95487.1c","article-title":"Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease","volume":"69","author":"Li","year":"2007","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD007514.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1172\/JCI0216421","article-title":"Isoprenoids as mediators of the biological effects of statins","volume":"110","author":"Liao","year":"2002","journal-title":"Journal of Clinical Investigation"},{"issue":"2","key":"10.1002\/14651858.CD007514.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0022-2275(20)32052-6","article-title":"Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients","volume":"41","author":"Lutjohann","year":"2000","journal-title":"Journal of Lipid Research"},{"issue":"12","key":"10.1002\/14651858.CD007514.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1136\/jnnp.2005.063388","article-title":"Lipid lowering agents are associated with a slower cognitive decline in Alzheimer's disease","volume":"76","author":"Masse","year":"2005","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD007514.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(13)61570-6","article-title":"A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II","volume":"382","author":"Matthews","year":"2013","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD007514.pub3-BIB0052|cit52","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003160.pub2","article-title":"Statins for the prevention of dementia","author":"McGuinness","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD007514.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/(SICI)1097-4547(19981001)54:1<58::AID-JNR7>3.0.CO;2-G","article-title":"Apolipoprotein E4 induces neuronal cell death under conditions of suppressed de novo cholesterol synthesis","volume":"54","author":"Michikawa","year":"1998","journal-title":"Journal of Neuroscience Research"},{"issue":"21","key":"10.1002\/14651858.CD007514.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"15110","DOI":"10.1074\/jbc.274.21.15110","article-title":"Cholesterol-dependent generation of a seeding amyloid beta-protein in cell culture","volume":"274","author":"Mizuno","year":"1999","journal-title":"Journal of Biological Chemistry"},{"key":"10.1002\/14651858.CD007514.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/00002093-199700112-00003","article-title":"Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope: The Alzheimer's Disease Cooperative Study","volume":"11 Suppl 2","author":"Mohs","year":"1997","journal-title":"Alzheimer Disease and Associated Disorders"},{"issue":"3","key":"10.1002\/14651858.CD007514.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1001\/jama.282.3.254","article-title":"Low-density lipoprotein cholesterol and the risk of dementia with stroke","volume":"282","author":"Moroney","year":"1999","journal-title":"JAMA"},{"issue":"8439","key":"10.1002\/14651858.CD007514.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(85)92866-1","article-title":"High-density lipoprotein cholesterol in differential diagnosis of senile dementia","volume":"1","author":"Muckle","year":"1985","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD007514.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/00006842-199707000-00008","article-title":"Serum cholesterol and intellectual performance","volume":"59","author":"Muldoon","year":"1997","journal-title":"Psychosomatic Medicine"},{"issue":"7","key":"10.1002\/14651858.CD007514.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0002-9343(00)00353-3","article-title":"Effects of lovastatin on cognitive function and psychological well-being","volume":"108","author":"Muldoon","year":"2000","journal-title":"American Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD007514.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0896-6273(95)90079-9","article-title":"Characterization of stable complexes involving apolipoprotein E and the amyloid beta peptide in Alzheimer's disease brain","volume":"15","author":"Naslund","year":"1995","journal-title":"Neuron"},{"issue":"1","key":"10.1002\/14651858.CD007514.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000026149","article-title":"Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease","volume":"17","author":"Notkola","year":"1998","journal-title":"Neuroepidemiology"},{"issue":"9119","key":"10.1002\/14651858.CD007514.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/S0140-6736(97)07541-7","article-title":"Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study","volume":"351","author":"Ott","year":"1998","journal-title":"Lancet"},{"issue":"10","key":"10.1002\/14651858.CD007514.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s00018-005-5406-7","article-title":"Lipid-lowering drugs","volume":"63","author":"Pahan","year":"2006","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"2-3","key":"10.1002\/14651858.CD007514.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0014-5793(97)00609-1","article-title":"Enhanced oxidizability of ubiquinol and alpha-tocopherol during lovastatin treatment","volume":"410","author":"Palomaki","year":"1997","journal-title":"FEBS Letters"},{"key":"10.1002\/14651858.CD007514.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3109\/00207454.2013.778846","article-title":"Role of statins in Alzheimer's disease: a retrospective meta-analysis for commonly investigated clinical parameters in RCTs","volume":"123","author":"Pandey","year":"2013","journal-title":"International Journal of Neuroscience"},{"issue":"2","key":"10.1002\/14651858.CD007514.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s004060200013","article-title":"Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia","volume":"252","author":"Paragh","year":"2002","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"issue":"8","key":"10.1002\/14651858.CD007514.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1212\/WNL.58.8.1175","article-title":"The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function","volume":"58","author":"Posner","year":"2002","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD007514.pub3-BIB0068|cit68","first-page":"321","article-title":"Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model","volume":"7","author":"Refolo","year":"2000","journal-title":"Neurobiological Disorders"},{"issue":"5","key":"10.1002\/14651858.CD007514.pub3-BIB0069|cit69","first-page":"890","article-title":"A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease","volume":"8","author":"Refolo","year":"2001","journal-title":"Neurobiological Disorders"},{"issue":"8","key":"10.1002\/14651858.CD007514.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.neurobiolaging.2003.11.009","article-title":"Cholesterol in neurologic disorders of the elderly: stroke and Alzheimer's disease","volume":"25","author":"Reiss","year":"2004","journal-title":"Neurobiology of Aging"},{"issue":"5","key":"10.1002\/14651858.CD007514.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1001\/archneur.61.5.705","article-title":"Relation of plasma lipids to Alzheimer disease and vascular dementia","volume":"61","author":"Reitz","year":"2004","journal-title":"Archives of Neurology"},{"issue":"9","key":"10.1002\/14651858.CD007514.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1111\/j.1532-5415.2004.52405.x","article-title":"Effect of vascular lesions on cognition in Alzheimer's disease: a community-based study","volume":"52","author":"Riekse","year":"2004","journal-title":"Journal of the American Geriatrics Society"},{"issue":"7","key":"10.1002\/14651858.CD007514.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S0022-2275(20)37414-9","article-title":"Effects of simvastatin on the metabolism of polyunsaturated fatty acids and on glycerolipid, cholesterol, and de novo lipid synthesis in THP-1 cells","volume":"38","author":"Rise","year":"1997","journal-title":"Journal of Lipid Research"},{"issue":"2","key":"10.1002\/14651858.CD007514.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/archneur.59.2.223","article-title":"Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people","volume":"59","author":"Rockwood","year":"2002","journal-title":"Archives of Neurology"},{"issue":"12","key":"10.1002\/14651858.CD007514.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1046\/j.1532-5415.2002.50631.x","article-title":"New possible role of statins in age-related diseases","volume":"50","author":"Ruocco","year":"2002","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1002\/14651858.CD007514.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0022-510X(02)00290-3","article-title":"Plasma antioxidant activity and vascular dementia","volume":"203-204","author":"Ryglewicz","year":"2002","journal-title":"Journal of Neurological Science"},{"key":"10.1002\/14651858.CD007514.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1586\/ern.11.171","article-title":"Statins to treat Alzheimer's disease: an incomplete story","volume":"12","author":"Sabbagh","year":"2012","journal-title":"Expert Reviews in Neurotherapeutics"},{"issue":"2","key":"10.1002\/14651858.CD007514.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","article-title":"Alzheimer's disease: genes, proteins, and therapy","volume":"81","author":"Selkoe","year":"2001","journal-title":"Physiological Review"},{"issue":"7","key":"10.1002\/14651858.CD007514.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1161\/01.ATV.14.7.1098","article-title":"Associations of lipoprotein cholesterols, apolipoproteins A-I and B, and triglycerides with carotid atherosclerosis and coronary heart disease. The Atherosclerosis Risk in Communities (ARIC) Study","volume":"14","author":"Sharrett","year":"1994","journal-title":"Arteriosclerosis Thrombosis"},{"issue":"11","key":"10.1002\/14651858.CD007514.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1001\/archneurol.2011.242","article-title":"Cholesterol level and statin use in Alzheimer disease. II. Review of human trials and recommendations","volume":"68","author":"Shepardson","year":"2011","journal-title":"Archives in Neurology"},{"issue":"11","key":"10.1002\/14651858.CD007514.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"6460","DOI":"10.1073\/pnas.95.11.6460","article-title":"Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons","volume":"95","author":"Simons","year":"1998","journal-title":"Proceedings of the National Academy of Science of the USA"},{"issue":"6","key":"10.1002\/14651858.CD007514.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1212\/WNL.57.6.1089","article-title":"Cholesterol and Alzheimer's disease: is there a link?","volume":"57","author":"Simons","year":"2001","journal-title":"Neurology"},{"issue":"10","key":"10.1002\/14651858.CD007514.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.1997.03540340047031","article-title":"Brain infarction and the clinical expression of Alzheimer's disease. The Nun Study","volume":"277","author":"Snowdon","year":"1997","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD007514.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMoa061894","article-title":"High-dose atorvastatin after stroke or transient ischaemic attack","volume":"355","author":"SPARCL Investigators","year":"2006","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD007514.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0197-4580(90)90024-T","article-title":"Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease","volume":"11","author":"Sparks","year":"1990","journal-title":"Neurobiology of Aging"},{"issue":"1","key":"10.1002\/14651858.CD007514.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/exnr.1994.1044","article-title":"Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol","volume":"126","author":"Sparks","year":"1994","journal-title":"Experimental Neurology"},{"key":"10.1002\/14651858.CD007514.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1600-0404.2006.00690.x","article-title":"Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trial","volume":"185","author":"Sparks","year":"2006","journal-title":"Acta Neurology Scandinavia Supplement"},{"issue":"2","key":"10.1002\/14651858.CD007514.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1464-5491.1999.00027.x","article-title":"Type 2 diabetes mellitus, cognitive impairment and dementia","volume":"16","author":"Stewart","year":"1999","journal-title":"Diabetes Medicine"},{"key":"10.1002\/14651858.CD007514.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jns.2012.10.018","article-title":"Midlife vascular risk factors and their association with dementia deaths: results from a Norwegian prospective study followed up for 35 years","volume":"324","author":"Strand","year":"2013","journal-title":"Journal of the Neurological Sciences"},{"issue":"17","key":"10.1002\/14651858.CD007514.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"8098","DOI":"10.1073\/pnas.90.17.8098","article-title":"Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"issue":"10","key":"10.1002\/14651858.CD007514.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/ng1009-1047","article-title":"Alzheimer's disease beyond APOE","volume":"41","author":"Es","year":"2009","journal-title":"Nature Genetics"},{"issue":"6","key":"10.1002\/14651858.CD007514.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/ana.10220","article-title":"Association between high-density lipoprotein and cognitive impairment in the oldest old","volume":"51","author":"Exel","year":"2002","journal-title":"Annals of Neurology"},{"issue":"43","key":"10.1002\/14651858.CD007514.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"44945","DOI":"10.1074\/jbc.M407986200","article-title":"Association of gamma-secretase with lipid rafts in post-Golgi and endosome membranes","volume":"279","author":"Vetrivel","year":"2004","journal-title":"Journal of Biological Chemistry"},{"issue":"2 Suppl 1","key":"10.1002\/14651858.CD007514.pub3-BIB0094|cit94","first-page":"S69","article-title":"Amyloidogenic processing of beta-amyloid precursor protein in intracellular compartments","volume":"66","author":"Vetrivel","year":"2006","journal-title":"Neurology"},{"issue":"5","key":"10.1002\/14651858.CD007514.pub3-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1001\/archneur.56.5.587","article-title":"Aging and the occurrence of dementia: findings from a population-based cohort with a large sample of nonagenarians","volume":"56","author":"Strauss","year":"1999","journal-title":"Archives of Neurology"},{"issue":"7","key":"10.1002\/14651858.CD007514.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1592\/phco.23.7.871.32720","article-title":"Statin-associated memory loss: analysis of 60 case reports and review of the literature","volume":"23","author":"Wagstaff","year":"2003","journal-title":"Pharmacotherapy"},{"issue":"4","key":"10.1002\/14651858.CD007514.pub3-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1177\/019262339602400409","article-title":"Subchronic toxicity of atorvastatin, a hydroxymethylglutaryl-coenzyme A reductase inhibitor, in beagle dogs","volume":"24","author":"Walsh","year":"1996","journal-title":"Toxicology Pathology"},{"issue":"6","key":"10.1002\/14651858.CD007514.pub3-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1161\/01.HYP.37.6.1450","article-title":"HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species","volume":"37","author":"Wassmann","year":"2001","journal-title":"Hypertension"},{"issue":"8955","key":"10.1002\/14651858.CD007514.pub3-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(95)90701-7","article-title":"Is Alzheimer's disease an apolipoprotein E amyloidosis?","volume":"345","author":"Wisniewski","year":"1995","journal-title":"Lancet"},{"issue":"10","key":"10.1002\/14651858.CD007514.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"5371","DOI":"10.1073\/pnas.101123198","article-title":"A fluid connection: cholesterol and Abeta","volume":"98","author":"Wolozin","year":"2001","journal-title":"Proceedings of the National Academy of Science USA"},{"issue":"6","key":"10.1002\/14651858.CD007514.pub3-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00702-002-0809-1","article-title":"Brain region-dependent increases in beta-amyloid and apolipoprotein E levels in hypercholesterolemic rabbits","volume":"110","author":"Wu","year":"2003","journal-title":"Journal of Neural Transmission"},{"issue":"6","key":"10.1002\/14651858.CD007514.pub3-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1212\/WNL.45.6.1161","article-title":"Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study","volume":"45","author":"Yoshitake","year":"1995","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD007514.pub3-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/ajcn\/80.2.291","article-title":"Serum cholesterol concentrations are associated with visuomotor speed in men: findings from the third National Health and Nutrition Examination Survey, 1988-1994","volume":"80","author":"Zhang","year":"2004","journal-title":"American Journal of Clinical Nutrition"},{"issue":"3","key":"10.1002\/14651858.CD007514.pub3-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000099037","article-title":"Prevention and treatment of dementia or Alzheimer's disease by statins: a meta-analysis","volume":"23","author":"Zhou","year":"2007","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"key":"10.1002\/14651858.CD007514.pub3-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2318-1-5","article-title":"Lipoprotein profile in older patients with vascular dementia and Alzheimer's disease","volume":"1","author":"Zuliani","year":"2001","journal-title":"BMC Geriatrics"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD007514.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T10:32:46Z","timestamp":1716460366000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD007514.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Dementia and Cognitive Improvement Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,7,8]]},"references-count":105,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2014,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007514.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,8]]}}}